New Delhi: A day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting permission for emergency use of the Oxford vaccine, the expert panel on Saturday gave similar direction for the indigenously developed coronavirus vaccine Covaxin with certain conditions.
Bharat Biotech, which has developed Covaxin in collaboration with Indian Council of Medical Research (ICMR), had applied to the Drugs Controller General Of India (DCGI) seeking emergency use authorisation (EUA) for its Covaxin on December 7.
The expert committee, which had asked for further data on its phase 3 trials, again deliberated on emergency use application of the Hyderabad-based pharma company after they submitted additional data, facts and analysis, The Indian Express reported.
Also Read: Govt Panel Okays Oxford Vaccine In India, DCGI To Take Final Call On Rollout
Also Read: After Pfizer & SII, Bharat Biotech Too Seeks Emergency Use Approval For Covaxin
Also Read: Covaxin Capable Of Dealing With New COVID Strains, Says Bharat Biotech Chairman
Bargarh: A new artist will be selected to play the mythological character King Kansa during…
Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…